See More Hear More Watch More Hear More Get on iTunes
Bloomberg First Word BloombergFirst

Shares of Gilead-Sciences Up More than 3%

Shares of Gilead-Sciences up more than 3%. The maker of the hepatitis C drugs posted second quarter profit that topped analysts estimates as revenues surged. #FinancialNews


More from